Literature DB >> 8151381

Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.

N Tamaki1, N Takahashi, M Kawamoto, T Torizuka, E Tadamura, Y Yonekura, K Okuda, R Nohara, S Sasayama, J Konishi.   

Abstract

UNLABELLED: To assess the clinical value of the 99mTc-labeled myocardial perfusion agent, 99mTc-tetrofosmin, the findings of stress and rest myocardial tomography were compared with those of stress and 3-hr delayed 201Tl tomography and coronary arteriography.
METHODS: Twenty-five patients who had coronary arteriography were studied with both stress tetrofosmin and 201Tl tomography.
RESULTS: The image quality of tetrofosmin was superior to that of 201Tl despite a shorter acquisition time. Both the tetrofosmin and 201Tl studies were quite sensitive to detect coronary artery disease (100% and 95%, respectively) (p = ns). The two studies showed similar sensitivity (75% and 73%) and specificity (80% and 77%, respectively) for the detection of significant (> or = 75% diameter) coronary artery stenosis. Stress distribution of tetrofosmin tended to be slightly higher than that of 201Tl (% uptake: 63.3% +/- 13.5% versus 60.4% +/- 12.2%, p = 0.0006; uptake score: 2.33 +/- 1.03 versus 2.22 +/- 1.07, p = 0.007), indicating less defect contrast in the former. A high concordant rate (89%) of the stress perfusion score was observed between the two radiopharmaceuticals. Reversible perfusion abnormalities were observed to be similar between stress-rest tetrofosmin and stress-delayed 201Tl studies.
CONCLUSIONS: Stress tetrofosmin perfusion tomography is a valuable method to detect coronary artery disease and to assess tissue viability with accuracy similar to that of stress 201Tl tomography.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151381

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging.

Authors:  C Y Loong; C Anagnostopoulos
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  (99m)Tc-tetrofosmin as a prognostic agent?

Authors:  Ichiro Matsunari; Junichi Taki; Kenichi Nakajima; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01       Impact factor: 9.236

4.  Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy.

Authors:  T Fukuda; M Ishibashi; T Shinohara; T Miyake; T Kudoh; T Saga
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

Review 5.  Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging.

Authors:  J T Keijer; J J Bax; A C van Rossum; F C Visser; C A Visser
Journal:  Int J Card Imaging       Date:  1997-10

6.  Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.

Authors:  E Nicolai; A Cuocolo; W Acampa; A Varrone; L Pace; M Salvatore
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

7.  Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201.

Authors:  N Takahashi; S T Dahlberg; M P Gilmore; J A Leppo
Journal:  J Nucl Cardiol       Date:  1997 Nov-Dec       Impact factor: 5.952

8.  Tc-99m tetrofosmin myocardial distribution 4 hours post injection.

Authors:  M Pillay; P H Cox; D H Schönfeld; S Mathews
Journal:  Int J Card Imaging       Date:  1996-06

9.  Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration.

Authors:  A Peix; A López; F Ponce; J Morales; A R de la Vega; C S Chesa; A M Maltas; D García-Barreto
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

10.  Tc-99m tetrofosmin myocardial SPECT perfusion imaging: comparison of rest-stress and stress-rest protocols.

Authors:  M M Boomsma; M G Niemeyer; E E van der Wall; B L van Eck-Smit; A H Zwinderman; J H Boomsma; E K Pauwels
Journal:  Int J Card Imaging       Date:  1998-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.